Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 20, 2008 08:12 ET | Source: Epigenomics AG

Epigenomics AG: Release of a Voting Rights Notification

BERLIN, Germany, Feb. 20, 2008 (PRIME NEWSWIRE) -- Voting Rights Notification (section 21 para. 1 WpHG) in accordance with section 26, para. 1 WpHG (German Securities Trading Act): On February 19,...
February 19, 2008 12:35 ET | Source: Epigenomics AG

Epigenomics Licenses Septin 9 Colorectal Cancer Biomarker to Quest Diagnostics

BERLIN, Feb. 19, 2008 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX) (Other OTC:EPGNF), a cancer molecular diagnostics company, today announced that it signed a non-exclusive licensing agreement...
February 19, 2008 12:28 ET | Source: Epigenomics AG

Epigenomics AG: Ad hoc (#15 WpHG): Epigenomics Licenses Septin 9 Colorectal Cancer Biomarker to Quest Diagnostics

BERLIN, Feb. 19, 2008 (PRIME NEWSWIRE) -- Epigenomics AG (Other OTC:EPGNF) (Frankfurt:ECX) today announced that it signed a non-exclusive licensing agreement for its proprietary DNA methylation...
October 31, 2007 03:42 ET | Source: Epigenomics AG

Epigenomics AG Reports Third Quarter 2007 Results

Key Figures (in EUR thousand) * Revenue: 466 in Q3 2007, down by 61% (Q3 2006: 1,203) * EBIT: -3,229 in Q3 2007, improved by 15% (Q3 2006: -3,790) * Net loss: -3,139 in Q3 2007, improved...
October 10, 2007 03:12 ET | Source: Epigenomics AG

Epigenomics AG Forms Medical Advisory Board For Colorectal Cancer Screening

BERLIN and SEATTLE, Oct. 10, 2007 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX) (ISIN:DE000A0BVT96) today announced the formation of its Colorectal Cancer Medical Advisory board and the...
October 04, 2007 03:13 ET | Source: Epigenomics AG

Epigenomics AG: Key Patents For Cancer Testing Granted

BERLIN and SEATTLE, Oct. 4, 2007 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX) (ISIN: DE000A0BVT96) today announced that key patents covering Epigenomics' core technology HeavyMethyl(r) for the...
September 26, 2007 02:24 ET | Source: Epigenomics AG

Ad hoc: Epigenomics AG: Ad Hoc (Section 15 WpHG): Epigenomics AG Announces Strategic In Vitro Diagnostics Partnership With Abbott Molecular

Collaboration Focuses On Development and Global Commercialization of a Molecular Diagnostic Test for the Early Detection of Colorectal Cancer * Abbott obtains non-exclusive worldwide rights to...
September 18, 2007 05:33 ET | Source: Epigenomics AG

Epigenomics AG Updates on Progress in Its Prostate Cancer Test Development

BERLIN and SEATTLE, Sept. 18, 2007 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX), a molecular diagnostics company focusing on the development and commercialization of in-vitro diagnostic tests...
August 02, 2007 02:39 ET | Source: Epigenomics AG

Epigenomics AG Reports First Half 2007 Results

Key Figures (in EUR thousand) * Revenues: 1,343 in H1 2007; increased by 23% (H1 2006: 1,096) * EBIT: -6,949 in H1 2007; improved by 18% (H1 2006: -8,431) * Net loss: -6,699 in H1 2007; reduced...
July 03, 2007 02:39 ET | Source: Epigenomics AG

Epigenomics AG Successfully Optimized Assay Procedure for Cancer Screening Tests

-- Technical study met its objectives -- Considerable improvements in simplicity, processing time, costs, and automation potential -- Epigenomics most advanced program, a colorectal cancer...